CME

CME


Seralutinib for Treatment of Group 1 PAH

June 28, 2023

Host: Oksana A. Shlobin, MD


While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved medicati